Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06217198 · ClinicalTrials.gov registry record · NA

A Computerized Depression Intervention in Veterans

A NA study of Depression, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
152
Enrollment target
1
Study location

NCT06217198: Recruiting NA study of Depression, sponsored by VA Office of Research and Development.

NCT06217198 is a NA study of Depression that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 152 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06217198, a NA study of Depression, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
152 participants
Enrollment target
1
Study location

Study Summary

Depressive symptoms are common among Veterans and associated with significant impairment. Timely intervention has the potential to improve mental health outcomes and restore functioning. Interventions delivered through the internet can be completed remotely at any time, and thus minimize burden on Veterans, however the research examining their utility in Veterans is limited. This proposed project will examine Deprexis, a self-guided internet-delivered intervention, which targets depressive symptoms and associated functional impairments. Interviews will be conducted to gain insight into Veterans' perceptions, needs, and preferences vis-a-vis Deprexis, with results informing a randomized controlled trial. Here an 8-week course of Deprexis will be compared to a treatment-as-usual (TAU) control condition to establish if Deprexis is acceptable and effective for Veterans with mild to moderate depressive symptoms. Veterans engaged in Deprexis are hypothesized to show improvements on measures of functioning and decreases in depressive symptoms compared to the TAU control group. The proposed work has great clinical utility, as it could provide a readily accessible, high-quality intervention for the many Veterans suffering from depressive symptoms, with the potential to improve functioning and long-term outcomes.

Conditions Studied

Interventions

  • BEHAVIORAL Deprexis

Study Locations (1)

Texas

  • Central Texas Veterans Health Care System Waco VA Medical Center, Waco, TX - Waco

Trial Details

FieldValue
Enrollment Target 152 participants
Start Date 2024-05-01
Est. Completion 2029-04-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT06217198

The ClinicalTrials.gov registry entry for NCT06217198 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Deprexis is the first listed.

NCT06217198 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06217198 about?

NCT06217198 is a clinical study titled "A Computerized Depression Intervention in Veterans". Depressive symptoms are common among Veterans and associated with significant impairment. Timely intervention has the potential to improve mental health outcomes and restore functioning. Interventions delivered through the internet can be completed remotely at any time, and thus minimize burden on V...

What is the current status of trial NCT06217198?

This trial is currently recruiting. It is a NA study. The enrollment target is 152 participants. The study started on 2024-05-01. Estimated completion is 2029-04-30.

What conditions does trial NCT06217198 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT06217198?

The interventions under investigation include: Deprexis (BEHAVIORAL).

Who is sponsoring clinical trial NCT06217198?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06217198 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.